§ Mrs. Lait
To ask the Secretary of State for Health, pursuant to her answer of 17 March,Official Report, column 303, when she expects the Advisory Committee on National Health Service Drugs to specify which existing products in the 10 new categories to be covered by the selected list regulations it will formally consider; and on what basis the selection will be made.
§ Dr. Mawhinney
The Advisory Committee on National Health Service Drugs has set up sub-groups to undertake preliminary consideration, in the light of the committee's terms of reference, of the range of drugs within each of the new therapeutic categories. These sub-groups will report to the full committee, which will decide which drugs should be formally considered. The committee has not set dates for the reviews of particular categories, but relevant manufacturers will be informed in advance.